RoyalMax Biotechnology Canada Inc. Signs Cannabis Genetics Supply Agreement with Rangers Pharmaceuticals
Matica Announces Delayed Filing of Annual Disclosure Documents Pursuant to OSC Blanket Instrument 51-502
Standard Uranium Provides Update on $3 Million Strategic Investment and Announces Extension to Closing Date of Private Placement
